Meridian Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
523
-399
| -43% | -$209K | 0.01% | 574 |
|
|
2025
Q1 | $585K | Hold |
922
| – | – | 0.03% | 382 |
|
|
2024
Q4 | $657K | Sell |
922
-97
| -10% | -$69.1K | 0.03% | 362 |
|
|
2024
Q3 | $1.07M | Buy |
1,019
+55
| +6% | +$57.8K | 0.05% | 273 |
|
|
2024
Q2 | $1.01M | Buy |
+964
| New | +$1.01M | 0.12% | 114 |
|
|
2024
Q1 | – | Sell |
-994
| Closed | -$873K | – | 434 |
|
|
2023
Q4 | $873K | Buy |
994
+91
| +10% | +$79.9K | 0.06% | 280 |
|
|
2023
Q3 | $743K | Sell |
903
-4
| -0.4% | -$3.29K | 0.05% | 287 |
|
|
2023
Q2 | $652K | Buy |
907
+85
| +10% | +$61.1K | 0.05% | 275 |
|
|
2023
Q1 | $675K | Buy |
822
+487
| +145% | +$400K | 0.06% | 269 |
|
|
2022
Q4 | $242K | Buy |
+335
| New | +$242K | 0.02% | 459 |
|
|
2020
Q4 | – | Sell |
-540
| Closed | -$302K | – | 346 |
|
|
2020
Q3 | $302K | Sell |
540
-1,034
| -66% | -$578K | 0.07% | 187 |
|
|
2020
Q2 | $981K | Buy |
1,574
+1,004
| +176% | +$626K | 0.33% | 68 |
|
|
2020
Q1 | $278K | Buy |
+570
| New | +$278K | 0.12% | 159 |
|